4/A

PRIMARY DOCUMENT

Company: IONIS PHARMACEUTICALS INC
Filed: January 31, 2020
Period of Report: January 2, 2020
Accession Number: 0000874015-20-000043

View Document ↗ View on SEC.gov ↗